Biogenes Technologies Sdn Bhd (Biogenes), a Malaysian biotech startup, has bagged US$5.7 million for its Series A funding from Pembangunan Ekuiti Sdn Bhd (PESB), according to a January 18 press release. “With this support, Biogenes will invest into a medical-grade manufacturing facility, advancing our technology portfolio,” said Tang KM, the co-founder and CEO of Biogenes. Source: Vulcan Post. 18/1/2023